Business
Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results
Full-Year Net Revenue Increased 33% Y-O-Y to $18.8 Million and Fourth-Quarter Net Revenue up 22% Y-O-Y to $4.7 Million Reports Second Consecutive Year of
About this update from Nephros, Inc.
[{"type":"text","content":"Full-Year Net Revenue Increased 33% Y-O-Y to $18.8 Million and Fourth-Quarter Net Revenue up 22% Y-O-Y to $4.7 Million Reports Second Consecutive Year of Positive Net Income SOUTH ORANGE, N.J., March 12, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2025. Financial HighlightsFourth Quarter Ended December 31, 2025. Net revenue was $4.7 million, compared to $3.9 million in the fourth quarter of 2024, up 22%Net income was $62,000, compared to $349,000 during the same period in 2024Adjusted EBITDA was $131,000, compared to $481,000 in the fourth quarter of 2024 Year-End 2025 Net revenue was $18.8 million, compared to $14.2 million for the year ended December 31, 2024, up 33%Net income was $1.2 million, compared with $74,000 in 2024Adjusted EBITDA was $1.6 million, compared with $548,000 in 2024 “2025 was transformational for Nephros,” said Robert Banks, President and Chief Executive Officer. “We delivered 33% revenue growth following a record year in 2024 and we achieved the highest revenue in a quarter in our history. This performance reflects execution of a clear, disciplined strategy built around three growth pillars: Products, Service, and Education.” “Our differentiated product portfolio remains at the center of our success. Continued expansion of reorder rates, deployment of additional sales associates, and growth beyond traditional healthcare applications drove meaningful revenue gains in 2025. Further, we extended our long-term supply agreement with our key partner, Medica, ensuring continuity of supply and supporting sustained multi-year growth.” “We also advanced our service offering through the expansion of installation and replacement capabilities led by Alfred Vargas, Director of Service. The development of these functions in-house has meaningfully reduced barriers to adoption, strengthened customer relationships, and increased opportunities for recurring revenue.” “Additionally, we launched the Nephros Water Institute, led by Brianne McGuire, Director of Business Development, a major milestone in establishing Nephros as an authority in waterborne pathogen mitigation and facility water safety. The Institute expands ou...